3/24/2021Hutchmed Sells Non-core OTC Chinese JV with Baiyunshan for $169M

3/24/2021Ping An and Zhongshan Hospital Join Hands for Healthcare+Technology+Fi...

3/24/2021Pharma Manufacturing Industry Lag and Potential for China's Five-Year ...

3/23/2021Takeda Unveils Open Incubation Platform as Part of Its Digital Strateg...

3/23/2021China Introduces New Program for Early Access to New Drugs in the Grea...

3/23/2021Eucure Announces Breakthu Phase I Results for Anti-CTLA-4 in Combo wit...

3/23/2021EpimAb Raises $120M Pre-IPO with Global Expansion Aspirations

3/23/2021NMPA Revises Packages Insert of Mouse Nerve Growth Factor

3/23/2021NIFDC Issues the 2020 National Drug Sample Inspection Annual Report

3/22/2021Bayer Launches Prostate Cancer Drugs Nubeqa and Xofigo in China

3/22/2021Sesen and Qilu Announce Chinese IND Approval for Vicineum

3/19/2021Recent Executive Moves

3/18/2021WuXi Biologics to Acquire CMAB and Form Strategic Partnership with CBC...

3/18/2021Complix Agrees with I-Mab to Develop Cell Penetrating Alphabodies aga...

3/18/2021NMPA Revises Packages Inserts of Sodium Ferulate for Injection

3/18/2021Ping An Good Doctor: Cross-Sectional Survey

3/17/2021NHSA Releases Its 2020 Healthcare Security Sector Development Statisti...

3/16/2021CDE Issues the Technical Requirements for Topical Dermatological Gener...

3/16/2021Chinese Chemical Drug Manufacturing Industry Revenue Down Slightly in ...

3/16/2021Italfarmaco Group Agreed with Luye Pharma to Commercialize Rivastigmi...

3/16/2021Pfizer to Halt Biosimilar Production in China and Sell Its Hangzhou Bi...

3/16/2021Remegen Wins China Approval for Lupus Drug Telitacicept

3/16/2021BeiGene Announces Acceptance of a Supplemental Biologics License Appli...

3/16/2021Patent Term Extension in China

3/15/2021Highlights of the 14th Five Year Plan Covers Various Aspects of Health...

3/12/2021CDE Issues the Guidelines for Acceptance and Evaluation of TCM Changes

3/12/2021Recent Executive Moves

3/11/2021NHSA Initiates DRG-based Medical Insurance Payment in Simulation Run

3/10/2021Alphamab's IND for Phase II Pivotal Trial of KN046 Cleared in the U.S...

3/10/2021Wugen Enter Partnership with Alpha Biopharma in Asia for Cell Therapie...

Page:94/357 Total number of articles:10684: [First][<<] [92] [93] [94] [95] [96] [>>] [End]